title: Why change injection sites for depot antipsychotic medication?
authors.forename: Alicia
authors.initials: A
authors.lastname: Cox
authors.forename: Brett
authors.initials: B
authors.lastname: Emmerson
authors.forename: Bruce
authors.initials: B
authors.lastname: Collyer
authors.forename: James
authors.initials: J
authors.lastname: Scott
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects / Q000379:methods; D009736:Nursing Process / Q000592:standards*; D059348:Peripheral Nerve Injuries / Q000209:etiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations